Cognitive therapy for psychosis (CBTp), schizophrenia and psychotic symptoms has advanced rapidly over the past two decades and is having an increasing influence on clinical practice.Research has focused on symptoms, e.g. paranoia, negative symptoms and hallucinations, and stages of the disorder, e.g. early intervention and persistent symptoms. It has used a range of approaches, e.g. brief or lengthier interventions for individual and groups, and in different cultural settings.Recent meta-analyses of studies demonstrate that CBTp has benefits over and above medication and treatment as usual with moderate effect sizes. This is less with active controls, e.g. supportive therapy or befriending, but a consistent finding across studies.Depression in psychosis, people on clozapine and those who are not taking medication, are areas where research is occurring but further research is needed, e.g. for both younger and older patients, late onset psychosis, learning disability, forensic patients and with substance abuse.